30mg High Concentration GS-441524 Injections RdRp Inhibition

30mg High Concentration GS-441524 Injections RdRp Inhibition Stable Purity

Product Overview

For advanced feline viral research, the concentration of the active ingredient is a decisive factor. GS-441524 is the primary active metabolite of the antiviral pro-medication RDV, maintaining a consistent 24-hour half-life in physiological systems. Our 30mg/mL high-potency formula is engineered to provide superior viral suppression for feline subjects where standard concentrations may fall short.

The molecular mechanism centers on inhibiting the RNA-dependent RNA polymerase (RdRp). In simple terms, the GS-441524 molecule mimics natural building blocks to insert itself into the viral RNA chain, effectively "jamming" the replication machinery. This prevents the systemic spread of the virus, especially in cats whose immune systems are struggling to form sufficient antibodies.

Technical Parameters:

Applications & Dosage

• Targeted Scenarios: Highly recommended for neurological and ocular symptoms where higher penetration is required.
• Standard Cycle: 12 weeks of daily administration.
• Dosage Reference:
  • FIP (Wet/Effusive): 0.4mL/kg * body weight + 0.1 residue.
  • Neurological/Ocular: 0.7mL/kg * body weight + 0.1 residue.

Storage Protocol 

Store at 2~4°C for maximum stability. Do not freeze. Temperatures below zero will cause the 30mg high-concentration solute to precipitate, forming crystals that alter the therapeutic effect and dosage accuracy.